Original Papers- KOSEKI Yoshitaka -
number of results to view: what to display: sort:
total:15
[2019]
1.A facile synthesis of (+)/(−)-pentenomycin I and analogs, and their antimicrobial evaluation.[Tetrahedron Letters,60,(2019),1375-1378]Takaaki Kamishima, Masato Suzuki, Shigenobu Aoyagi, Toshihiro Watanabe, Yoshitaka Koseki, Hitoshi Kasai
10.1016/j.tetlet.2019.04.026
http://www.scopus.com/inward/record.url?eid=85064451535&partnerID=40
2.Formation of five-membered carbocycles from D-glucose: A Concise Synthesis of 4-Hydroxy-2-(hydroxymethyl)cyclopentenone.[Bulletin of the Chemical Society of Japan,92,(2019),1324-1328]Yoshitaka Koseki, Toshihiro Watanabe, Takaaki Kamishima, Eunsang Kwon, Hitoshi Kasai
10.1246/bcsj.20190063
http://www.scopus.com/inward/record.url?eid=85072201269&partnerID=40
3.Influence of hydrolysis susceptibility and hydrophobicity of SN-38 nano-prodrugs on their anticancer activity.[Bulletin of the Chemical Society of Japan,92,(2019),1305-1313]Yoshitaka Koseki, Yoshikazu Ikuta, Liman Cong, Mayumi Takano-Kasuya, Hiroshi Tada, Mika Watanabe, Kohsuke Gonda, Takanori Ishida, Noriaki Ohuchi, Keita Tanita, Farsai Taemaitree, Anh Thi Ngoc Dao, Tsunenobu Onodera, Hidetoshi Oikawa, Hitoshi Kasai
10.1246/bcsj.20190088
http://www.scopus.com/inward/record.url?eid=85072204385&partnerID=40
[2018]
4.One-Step Conversion to a Disubstituted Cyclopentenone from 2-Deoxy-D-Glucose and Application to Synthesis of Prostaglandin E-1 Methyl Ester.[Bulletin of the Chemical Society of Japan,91(12),(2018),1691-1696]Kamishima Takaaki, Nonaka Toshiyuki, Watanabe Toshihiro, Koseki Yoshitaka, Kasai Hitoshi
10.1246/bcsj.20180241
http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=TohokuUniv&SrcApp=TohokuUniv&DestLinkType=FullRecord&KeyUT=WOS:000452402500002&DestApp=WOS
[2017]
5.Synthesis of ordered carbonaceous frameworks from organic crystals.[Nature Communications,8,(2017),109-1-109-9]H. Nishihara, T. Hirota, K. Matsuura, M. Ohwada, N. Hoshino, T. Akutagawa, T. Higuchi, H. Jinnai, Y. Koseki, H. Kasai, Y. Matsuo, J. Maruyama, Y. Hayasaka, H. Konaka, Y. Yamada, S. Yamaguchi, K. Kamiya, T. Kamimura, H. Nobukuni, F. Tani
10.1038/s41467-017-00152-z
6.Creation of nano eye-drops and effective drug delivery to the interior of the eye.[Scientific Reports,7,(2017),44229-]Y. Ikuta, S. Aoyagi, Y. Tanaka, K. Sato, S. Inada, Y. Koseki, T. Onodera, H. Oikawa, H. Kasai
10.1038/srep44229
[2016]
7.Drug Release is Determined by the Chain Length of Fatty Acid-Conjugated Anticancer Agent as One Component of the Nano-prodrugs.[Bulletin of the Chemical Society of Japan,89(5),(2016),540-545]Yoshitaka Koseki, Yoshikazu Ikuta, Takaaki Kamishima, Tsunenobu Onodera, Hidetoshi Oikawa, Hitoshi Kasai
10.1246/bcsj.20150405
8.12T061A and 12T061C, two new julichrome family compounds, as radical scavengers from Streptomyces sp..[The Journal of General and Applied Microbiology,62(1),(2016),1-6]Toshikazu Komoda, Naoko Saeki, Yoshitaka Koseki, Hiromasa Kiyota
10.2323/jgam.62.1
[2015]
9.Cytotoxicity of pure nanodrugs of SN-38 and podophyllotoxin dimers in human cancer HepG2, KPL-4, and MCF-7 cells.[Molecular Crystals and Liquid Crystals,622,(2015),1-5]Yoshitaka Koseki, Yoshikazu Ikuta, Tatsuya Murakami, Tsunenobu Onodera, Hidetoshi Oikawa, Liman Cong, Hiroshi Tada, Kohsuke Gonda, Noriaki Ohuchi & Hitoshi Kasai
10.Cytotoxicity of Pure Nanodrugs of SN-38 and Podophyllotoxin Dimers in Human Cancer HepG2, KPL-4, and MCF-7 Cells.[Molecular Crystals and Liquid Crystals,622(1),(2015),1-5]Yoshitaka Koseki, Yoshikazu Ikuta, Tatsuya Murakami, Tsunenobu Onodera, Hidetoshi Oikawa, Liman Cong, Hiroshi Tada, Kohsuke Gonda, Noriaki Ohuchi, Hitoshi Kasai
10.1080/15421406.2015.1096483
http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=TohokuUniv&SrcApp=TohokuUniv&DestLinkType=FullRecord&KeyUT=WOS:000366675500001&DestApp=WOS
11.The effect of molecular structure on the anticancer drug release rate from prodrug nanoparticles.[Chemical Communications,51(64),(2015),12835-12838]Yoshikazu Ikuta, Yoshitaka Koseki, Tsunenobu Onodera, Hidetoshi Oikawa, Hitoshi Kasai
[2014]
12.12T061C, a new Julichrome family radical scavenger from Streptomyces species.[Heterocyclic Communications,20(5),(2014),271-274]Toshikazu Komoda, Naoko Saeki, Yoshitaka Koseki, Hiromasa Kiyota
10.1515/hc-2014-0126
http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=TohokuUniv&SrcApp=TohokuUniv&DestLinkType=FullRecord&KeyUT=WOS:000343262900003&DestApp=WOS
13.Fabrication of podophyllotoxin nanoparticles as pure nanodrugs and their anti-cancer properties.[21st International Congress of Chemical and Process Engineering, CHISA 2014 and 17th Conference on Process Integration, Modelling and Optimisation for Energy Saving and Pollution Reduction, PRES 2014,2,(2014),1132-1133]Kasai H, Ikuta Y, Koseki Y, Onodera T, Murakami T, Ueda M, Oikawa H.
[2013]
14.Fabrication of Pure Nanodrugs of Podophyllotoxin Dimer and Their Anticancer Activity.[Chemistry Letters,48(8),(2013),900-901]Yoshikazu Ikuta, Yoshitaka Koseki, Tatsuya Murakami, Minoru Ueda, Hidetoshi Oikawa, Hitoshi Kasai
[2012]
15.Creation of pure nanodrugs and their anticancer properties..[Angewandte Chemie (International ed. in English),51(41),(2012),10315-10318]Kasai H, Murakami T, Ikuta Y, Koseki Y, Baba K, Oikawa H, Nakanishi H, Okada M, Shoji M, Ueda M, Imahori H, Hashida M
10.1002/anie.201204596
http://www.ncbi.nlm.nih.gov/pubmed/22969010 http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=TohokuUniv&SrcApp=TohokuUniv&DestLinkType=FullRecord&KeyUT=WOS:000309406900020&DestApp=WOS
Page: [1]
BackTop
copyright(c)2005 Tohoku University